Advanced Search

 

Study ID Status Title Patient Level Data
S3A290 Completed A Randomized, Double-Blind Comparison of Intravenous GR-C507/75 (Ondansetron) and Placebo in the Treatment of Postoperative Nausea and Vomiting
S3A-291 Completed A Double-Blind Evaluation of Oral GR-38032F in the Prevention of Delayed Nausea and Vomiting Associated With High-Dose Cisplatin
S3A30020 Completed A Randomised, Double-Blind Comparison of Ondansetron Suppository and Oral Ondansetron in the Prevention of Emesis and Nausea Associated with Cyclophosphamide Chemotherapy
S3A30023 Completed A Randomised Double-Blind Study to Compare the Efficacy and Safety of Oral GR38032F with Metoclopramide in the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy Regimen(s) Containing Epirubicin and Cyclophosphamide
S3A30024 Completed A Multicentre Double-Blind Study to Compare the Efficacy and Safety of GR38032F with Metoclopramide in the Prophylaxis of Chemotherapy Emesis Induced by FAC/FEC Regimens.
S3A30026 Completed A Randomised Double-Blind Study to Compare the Efficacy and Safety of GR38032F with Metoclopramide in the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy Regimens Containing Cyclophosphamide in Combination with Doxorubicin or Epirubicin
S3A30027 Completed A Multicentre Double-Blind Study to Compare the Efficacy and Safety of GR38032F with Metoclopramide in the Prophylaxis of Acute and Delayed Nausea and Vomiting Induced by Cisplatin-Containing Cancer Chemotherapy Regimens
S3A30034 Completed The Pharmacokinetics of Ondansetron Following a Single Intravenous Dose in Paediatric Patients Undergoing General Anaesthesia
S3A30035 Completed Prevention of Postoperative Nausea and Vomiting: A Randomized, Stratified, Double-Blind, Placebo-Controlled Study of Intravenous Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Male Subjects Undergoing Surgical Procedures on an Ambulatory Basis.
S3A30036 Completed A Randomised, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of a Single Intravenous Bolus Dose of Ondansetron 4mg in the Prevention of Postoperative Nausea and Emesis in Patients Having General Anesthesia and Undergoing Day-case Surgery for Inguinal Hern ...
S3A30040 Completed A Double-Blind, Placebo-Controlled, Dose-Ranging Study To Evaluate The Efficacy And Safety Of Intravenously Administered Ondansetron In The Prevention Of Post-Operative Nausea And Vomiting In Patients Having General Anaesthesia And Undergoing Major Gynaecological Surgery.
S3A30044 Completed A Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Orally Administered Ondansetron 8mg TDS in the Prevention of Post-Operative Nausea and Vomiting in Patients Having General Anaesthesia and Undergoing Major Gynaecological Surgery
S3A30045 Completed A Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Ondansetron in the Prevention of Post-Operative Nausea and Vomiting in Patients Having General Anaesthesia and Undergoing Major Gynaecological Surgery
S3A30049 Completed A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Intravenous Ondansetron for the Treatment of Postoperative Emesis in Pediatric Patients Undergoing Outpatient Surgery
S3A30054 Completed A Multicentre, Double-Blind, Randomized, Parallel Group Study to Compare the Efficacy and Safety of Oral Ondansetron 8mg BD and 16mg OD in the Control of Nausea and Emesis Induced by Cyclophosphamide Containing Chemotherapy in Cancer Patients
S3A30055 Completed A Multicentre, Double-Blind, Randomised, Parallel Group Study to Compare the Efficacy and Safety of Oral Ondansetron 8mg BD and 16mg OD in the Control of Nausea and Emesis Induced by Cyclophosphamide Containing Chemotherapy in Breast Cancer Patients
S3A30064 Completed A Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Orally Administered Ondansetron 16mg TDS In The Prevention Of Post-Operative Nausea And Vomiting In Patients Having General Anaesthesia And Undergoing Major Gynaecological Surgery.
S3A30065 Completed Risk-adapted management of postoperative nausea and postoperative vomiting: a phase III-study to assess safety and efficacy of intravenous ondansetron and oral disintegrating tablets of ondansetron.
S3A30067 Completed Ondansetron plus Placebo versus Ondansetron plus Dexamethasone under consideration of a risk score for the prophylaxis of post operative nausea and vomiting (PONV)
S3A-351 Completed A Single-Blind Evaluation of Intravenous GR-C507/75 Compared to Intravenous Metoclopramide in the Prevention of Nausea and Vomiting Associated With High-Dose Cisplatin
S3A-352 Completed A Randomized Double-Blind Comparison of Three Dose Levels of Intravenous GR-C507/75 (GR 38032F) in the Prevention of Nausea and Vomiting Associated with Cisplatin
S3A-354 Completed A Double-Blind Comparison of Intravenous GR-C507/75 (GR38032F) and Placebo in the Prevention of Nausea and Vomiting Associated With Cisplatin or Cyclophosphamide Chemotherapy
S3A356 Completed A Double-Blind Evaluation of Three Different Doses of Intravenous GR-C507/75 (Ondansetron) in the Prevention of Nausea and Vomiting Associated With a Multiple Day Regimen of Cisplatin
S3A-359 Completed A Randomized Double-Blind Comparison of Three Dose Levels of Intravenous GR-C507/75 in the Prevention of Nausea and Vomiting Associated With Cisplatin
S3A362 Completed A Randomized, Double-Blind, Placebo-Controlled Dose Range Evaluation of Oral GR 38032F in the Prevention of Nausea and Vomiting Associated With Non-Cisplatin Chemotherapy

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.